Bayer Net Worth 2006-2021 | BAYRY

Interactive chart of historical net worth (market cap) for Bayer (BAYRY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bayer net worth as of September 17, 2021 is $52.97B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $52.972B $47.287B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $434.939B 18.10
Roche Holding AG (RHHBY) Switzerland $319.781B 0.00
Pfizer (PFE) United States $249.329B 14.16
Novo Nordisk (NVO) Denmark $241.084B 33.46
Eli Lilly (LLY) United States $221.573B 28.77
AbbVie (ABBV) United States $190.996B 9.15
Novartis AG (NVS) Switzerland $188.736B 14.02
Merck (MRK) United States $182.183B 12.47
AstraZeneca (AZN) United Kingdom $175.360B 24.93
Sanofi (SNY) $121.515B 13.39
GlaxoSmithKline (GSK) United Kingdom $105.307B 13.21
H Lundbeck (HLUYY) Denmark $5.383B 10.32
Innoviva (INVA) United States $1.059B 5.69